Drug Shortage Report for MYLAN-VERAPAMIL SR
Report ID | 121246 |
Drug Identification Number | 02450496 |
Brand name | MYLAN-VERAPAMIL SR |
Common or Proper name | VERAPAMIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100BT, 500BT |
ATC code | C08DA |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-11-25 |
Actual start date | 2020-11-25 |
Estimated end date | 2021-01-12 |
Actual end date | 2020-11-30 |
Shortage status | Resolved |
Updated date | 2020-12-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v31 | 2020-12-01 | English | Compare |
v30 | 2020-11-30 | French | Compare |
v29 | 2020-11-30 | English | Compare |
v28 | 2020-11-25 | English | Compare |
v27 | 2020-11-10 | French | Compare |
v26 | 2020-11-10 | English | Compare |
v25 | 2020-11-05 | English | Compare |
v24 | 2020-11-03 | French | Compare |
v23 | 2020-11-03 | English | Compare |
v22 | 2020-10-20 | French | Compare |
v21 | 2020-10-20 | English | Compare |
v20 | 2020-10-14 | French | Compare |
v19 | 2020-10-14 | English | Compare |
v18 | 2020-10-14 | French | Compare |
v17 | 2020-10-14 | English | Compare |
v16 | 2020-09-30 | French | Compare |
v15 | 2020-09-30 | English | Compare |
v14 | 2020-09-22 | French | Compare |
v13 | 2020-09-22 | English | Compare |
v12 | 2020-09-14 | French | Compare |